EdgarLookup
10-Q XBRL

GENESIS BIOPHARMA FORM 10-Q

Company
IOVANCE BIOTHERAPEUTICS, INC.
Filed
January 25, 2013
Period of Report
September 30, 2012
Accession Number
0001513160-13-000022

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →